Cash Ratio Analysis of Acrivon Therapeutics Inc. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointCash Ratio of ACRV
Dec-239.58Excellent Cash Ratio | Dec-2219.61Excellent Cash Ratio | Growth-51.13% |
Cash Ratio Analysis of Acrivon Therapeutics Inc.
| Cash Ratio of Acrivon Therapeutics Inc. with value of 9.58 indicates that a company has generated more cash in a period than what is needed to pay off its current liabilities. |
| Cash Ratio of ACRV drastically fell by -51.13 % this year. |
Other Cash Ratio Related Info of ACRV that may interest you.
Acrivon Therapeutics Inc. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ACRV | 7.72 | 7.57 | 1.98 % | Biotechnology |
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents. more ..
Cash Ratio Related Ratios
| CurrentRatio | QuickRatio | DebtToEquityRatio |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Cash Ratio of Acrivon Therapeutics Inc.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|---|
| Cash Ratio | 9.58 | 19.61 | 34.18 | 2.58 |
| Change | -51.13 % | -42.64 % | 1223.62 % |
FY Chart of Cash Ratio of Acrivon Therapeutics Inc.
Note : All Data Generated at the End of Trading Hours (EOD Data)